Although the etiology of systemic lupus erythematosus (SLE) remains enigmatic, it is likely that antibodies to DNA are an integral component in many, though not all, cases. The caveat is necessary, because several reports (for review, see ref. 1) have indicated that 30% or more of patients who meet the widely accepted classification criteria (2) devised by the American College of Rheumatology (formerly, the American Rheumatism Association) do not have detectable anti-DNA antibodies. Although useful, the classification criteria are broadly based and allow the diagnosis of SLE in patients with diverse clinical and serologic features. Most patients without anti-DNA antibodies do have antinuclear antibodies of other specificities (e.g., anti-Sm, anti-Ro, anti-La). It is possible, though we doubt it, that more sensitive assays would detect anti-DNA antibodies in all SLE patients. Thus on balance, lupus should really be considered a generic term, encompassing several individual conditions.The presence of anti-DNA antibodies in the serum of SLE patients has long been considered both a marker of, and pathologic factor in, renal disease (3,4). Indeed, in our group of nearly 200 SLE patients, we have yet to see a patient with severe renal involve-